The ORF3 protein of Hepatitis E virus is a phosphoprotein that associates with the cytoskeleton

Journal of Virology

Volumn 71, Issue 12, 1997, Pages 9045-9053

  Zafrullah, Mohammad ^a   Ozdener, Mehmet Hakan ^a,c   Panda, Subrat Kumar ^b   Jameel, Shahid ^a  

^a INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY ICGEB   (India)

^b ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^c ONDOKUZ MAYIS UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CYCLE PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHOPROTEIN; VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; CELL STRAIN COS1; CYTOSKELETON; ESCHERICHIA COLI; HEPATITIS VIRUS; HEPATOMA CELL; HUMAN; HUMAN CELL; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; VIRUS CELL INTERACTION; VIRUS MUTANT;

EID: 1842293292     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.12.9045-9053.1997     Document Type: Article

References (43)

1. Alessi, D. R., A. Cuenda, P. Cohen, D. T. Dudley, and A. R. Saltiel. 1995. PD098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J. Biol. Chem. 270:27489-27494.
2. Alvarez, E., I. C. Northwood, F. A. Gonzalez, D. A. Latour, A. Seth, C. Abate, T. Curran, and R. J. Davis. 1991. Pro-Leu-Ser/Thr-Pro is a consensus primary sequence for substrate protein phosphorylation. J. Biol. Chem. 266: 15277-15285.
3. Avruch, J., X.-F. Zhang, and J. M. Kryiakis. 1994. Raf meets Ras: completing the framework of a signal transduction pathway. Trends Biochem. Sci. 19:279-283.
4. Aye, T. T., T. Uchida, X.-Z. Ma, F. Iida, T. Shikata, H. Zhuang, and K. M. Win. 1992. Complete nucleotide sequence of a hepatitis E virus isolated from the Xinjiang epidemic (1986-1988) of China. Nucleic Acids Res. 20:3512.
5. Bi, S. L., M. A. Purdy, K. A. McCaustland, H. S. Margolis, and D. W. Bradley. 1993. The sequence of hepatitis E virus isolated directly from a single source during an outbreak in China. Virus Res. 28:233-247.
6. Bradley, D. W. 1990. Enterically-transmitted non-A, non-B hepatitis. Br. Med. Bull. 46:442-461.
7. Chen, R. H., C. Sarnecki, and J. Blenis. 1992. Nuclear localization and regulation of erk-and rsk-encoded protein kinases. Mol. Cell. Biol. 12:915-927.
8. Cicirelli, M. F., S. L. Pelech, and E. G. Krebs. 1988. Activation of multiple protein kinases during the burst in protein phosphorylation that precedes the first meiotic cell division in Xenopus oocytes. J. Biol. Chem. 263:2009-2019.
9. mpk, the meiosis-activated myelin basic protein kinase. J. Biol. Chem. 266:15180-15184.
10. Davis, R. J. 1993. The mitogen-activated protein kinase signal transduction pathway. J. Biol. Chem. 268:14553-14556.
11. Duclos, B., S. Marcandier, and A. J. Cozzone. 1991. Chemical properties and separation of phosphoamino acids by thin-layer chromatography and/or electrophoresis. Methods Enzymol. 201:10-21.
12. Dudley, D. T., L. Pang, S. J. Decker, A. J. Bridges, and A. R. Saltiel. 1995. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc. Natl. Acad. Sci. USA 92:7686-7689.
13. El-Diery, W. S., T. Tokino, V. E. Velculescu, D. B. Levy, R. Parsons, J. M. Trent, D. Lin, W. E. Mercer, K. W. Kinzler, and B. Vogelstein. 1993. WAF1, a potential mediator of p53 tumor suppression. Cell 75:817-825.
14. Fry, K. E., A. W. Tam, M. M. Smith, J. P. Kim, K. C. Luk, L. M. Young, M. Piatak, R. A. Feldman, K. Y. Yun, M. A. Purdy, K. A. McCaustland, D. W. Bradley, and G. R. Reyes. 1992. Hepatitis E virus (HEV): strain variation in the nonstructural gene region encoding consensus motifs for an RNA-dependent RNA polymerase and an ATP/GTP binding site. Virus Genes 6: 173-185.
15. Heller, T., R. H. Purcell, K. R. Klimpel, and S. U. Emerson. 1996. Assessment of the function of the third open reading frame protein of the hepatitis E virus, abstr. A111, p. 79. In IX Triennial International Symposium on Viral Hepatitis and Liver Disease.
16. Hikada, H., M. Watanabe, and R. Kobayashi. 1991. Properties and use of H-series compounds as protein kinase inhibitors. Methods Enzymol. 201: 328-339.
17. 2+-inhibitable protein kinase that phosphorylates microtubule-associated protein 2 in vitro by growth factors, phorbol esters, and serum in quiescent cultured human fibroblasts. J. Biol. Chem. 263:5396-5401.
18. Huang, C. C., D. Nguyen, J. Fernandez, K. Y. Yun, K. E. Fry, D. W. Bradley, A. W. Tam, and G. R. Reyes. 1992. Molecular cloning and sequencing of the Mexico isolate of hepatitis E virus (HEV). Virology 191:550-558.
19. Jameel, S. Unpublished data.
20. Jameel, S., M. Zafrullah, M. H. Ozdener, and S. K. Panda. 1996. Expression in animal cells and characterization of the hepatitis E virus structural proteins. J. Virol. 70:207-216.
21. Kennelly, P. J., and E. G. Krebs. 1991. Consensus sequences as substrate specificity determinants for protein kinases and protein phosphatases. J. Biol. Chem. 266:15555-15558.
22. Khuroo, M. S. 1980. Study of an epidemic of non-A, non-B hepatitis: possibility of another human hepatitis virus distinct from post-transfusion non-A, non-B type. Am. J. Med. 68:818-823.
23. Khuroo, M. S., M. R. Teli, S. Skidmore, M. A. Sofi, and M. Khuroo. 1981. Incidence and severity of viral hepatitis in pregnancy. Am. J. Med. 70:252-255.
24. Koonin, E. V., and V. V. Dolja. 1993. Evolution and taxonomy of positive-strand RNA viruses: implications of comparative analysis of amino acid sequences. Crit. Rev. Biochem. Mol. Biol. 28:375-390.
25. Koonin, E. V., A. E. Gorbalenya, M. A. Purdy, M. N. Rozanov, G. R. Reyes, and D. W. Bradley. 1992. Computer-assisted assignment of functional domains in the nonstructural polyprotein of hepatitis E virus: delineation of an additional group of positive-stranded RNA plant and animal viruses. Proc. Natl. Acad. Sci. USA 89:8259-8263.
26. Meijer, L. 1995. Chemical inhibitors of cyclin-dependent kinases, p. 351-363. In L. Meijer, S. Guidet, and H. Y. L. Tung (ed.), Progress in cell cycle research, vol. 1. Plenum Press, New York, N.Y.
27. Miller, M. J. 1995. Viral taxonomy. Clin. Infect. Dis. 21:280.
28. Niederman, T. M., W. R. Hastings, and L. Ratner. 1993. Myristoylation-enhanced binding of the HIV-1 Nef protein to T cell skeletal matrix. Virology 197:420-425.
29. Niesters, H. G. M., and J. H. Strauss. 1990. Mutagenesis of the conserved 51-nucleotide region of Sindbis virus. J. Virol. 64:1639-1647.
30. Panda, S. K., S. K. Nanda, M. Zafrullah, I. H. Ansari, M. H. Ozdener, and S. Jameel. 1995. An Indian strain of hepatitis E virus (HEV): cloning, sequence and expression of the structural region and antibody responses in sera from individuals from an area of high-level HEV endemicity. J. Clin. Microbiol. 33:2653-2659.
31. Payne, D. M., A. J. Rossomando, P. Martino, A. K. Erickson, J.-H. Her, J. Shabanowitz, D. F. Hunt, M. J. Weber, and T. W. Sturgill. 1991. Identification of the regulatory phosphorylation sites in pp42/mitogen-activated protein kinase (MAP kinase). EMBO J. 10:885-892.
32. Pelech, S. L., and D. L. Charest. 1995. MAP kinase-dependent pathways in cell cycle control, p. 33-52. In L. Meijer, S. Guidet, and H. Y. L. Tung (ed.), Progress in cell cycle research, vol. 1. Plenum Press, New York, N.Y.
33. Purcell, R. H., and J. R. Ticehurst. 1988. Enterically transmitted non-A, non-B hepatitis: epidemiology and clinical characteristics, p. 131-137. In A. J. Zuckerman (ed.), Viral hepatitis and liver disease. Alan R. Liss, Inc., New York, N.Y.
34. Purdy, M. A., A. W. Tam, C. C. Huang, P. O. Yarbough, and G. R. Reyes 1993. Hepatitis E virus: a non-enveloped member of the "alpha-like" RNA virus supergroup? Semin. Virol. 4:319-326.
35. Ray, L. B., and T. W. Sturgill. 1987. Rapid stimulation by insulin of a serine/threonine kinase in 3T3-L1 adipocytes that phosphorylates microtubule-associated protein 2 in vitro. Proc. Natl. Acad. Sci. USA 84:1502-1506.
36. Reyes, G. R., C. C. Huang, A. W. Tam, and M. A. Purdy. 1993. Molecular organization and replication of hepatitis E virus (HEV). Arch. Virol. 7:15-25.
37. Swick, A. G., M. Janicot, T. Cheval-Kastelic, J. C. McLenithan, and M. D. Lane. 1992. Promoter-cDNA-directed heterologous protein expression in Xenopus laevis oocytes. Proc. Natl. Acad. Sci. USA 89:1812-1816.
38. Tam, A. W., M. M. Smith, M. E. Guerra, C. C. Huang, D. W. Bradley, K. E. Fry, and G. R. Reyes. 1991. Hepatitis E virus (HEV): molecular cloning and sequencing of the full-length viral genome. Virology 185:120-131.
39. Tamaoki, T. 1991. Use and specificity of Staurosporine, UCN-01 and Calphostin as protein kinase inhibitors. Methods Enzymol. 201:340-347.
40. Tsarev, S. A., S. U. Emerson, G. R. Reyes, T. S. Tsareva, L. J. Letgers, I. A. Malik, M. Iqbal, and R. H. Purcell. 1992. Characterization of a prototype strain of hepatitis E virus. Proc. Natl. Acad. Sci. USA 89:559-563.
41. Wong, D. C., R. H. Purcell, M. A. Sreenivasan, S. R. Prasad, and K. M. Pavri. 1980. Epidemic and endemic hepatitis in India: evidence for a non-A, non-B virus etiology. Lancet ii:876-879.
42. Xiong, Y., G. J. Hannon, H. Zhang, D. Casso, R. Kobayashi, and D. Beach. 1993. p21 is a universal inhibitor of cyclin kinases. Nature 366:701-704.
43. Yuckenberg, P. D., F. Witney, J. Geisselsoder, and J. McClary. 1991. Site-directed in vitro mutagenesis using uracil-containing DNA and phagemid vectors, p. 27-48. In M. J. McPherson (ed.), Directed mutagenesis: a practical approach. IRL Press, Oxford, England.